Selected research
Market Structure
Global Azithromycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Azithromycin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Azithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Azithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Azithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Azithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Azithromycin include Teva, Sandoz, Mylan, Zydus Pharmaceuticals, Pfizer, Anke Hengyi, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation and Wockhardt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Azithromycin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Azithromycin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Azithromycin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azithromycin market size, projected growth trends, production technologies, key applications, and end-use industries.
Azithromycin Segment by Company
Teva
Sandoz
Mylan
Zydus Pharmaceuticals
Pfizer
Anke Hengyi
Hainan Poly Pharm
Hainan Hailing Chemipharma Corporation
Wockhardt
Gland Pharma
CSPC Ouyi Pharmaceutical
Aurobindo Pharma
Akorn
Azithromycin Segment by Type
Injectables
Ophthalmics
Oral
Azithromycin Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Azithromycin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azithromycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azithromycin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azithromycin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Azithromycin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Azithromycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Azithromycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Azithromycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injectables
- Ophthalmics
- Oral
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Teva
- Sandoz
- Mylan
- Zydus Pharmaceuticals
- Pfizer
- Anke Hengyi
- Hainan Poly Pharm
- Hainan Hailing Chemipharma Corporation
- Wockhardt
- Gland Pharma
- CSPC Ouyi Pharmaceutical
- Aurobindo Pharma
- Akorn
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Azithromycin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Azithromycin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Azithromycin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Azithromycin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Azithromycin Market Dynamics
- 2.1 Azithromycin Industry Trends
- 2.2 Azithromycin Industry Drivers
- 2.3 Azithromycin Industry Opportunities and Challenges
- 2.4 Azithromycin Industry Restraints
3 Azithromycin Market by Manufacturers
- 3.1 Global Azithromycin Revenue by Manufacturers (2021-2026)
- 3.2 Global Azithromycin Sales by Manufacturers (2021-2026)
- 3.3 Global Azithromycin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Azithromycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Azithromycin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Azithromycin Manufacturers, Product Type & Application
- 3.7 Global Azithromycin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Azithromycin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Azithromycin Players Market Share by Revenue in 2025
- 3.8.3 2025 Azithromycin Tier 1, Tier 2, and Tier 3
4 Azithromycin Market by Type
- 4.1 Azithromycin Type Introduction
- 4.1.1 Injectables
- 4.1.2 Ophthalmics
- 4.1.3 Oral
- 4.2 Global Azithromycin Sales by Type
- 4.2.1 Global Azithromycin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Azithromycin Sales by Type (2021-2032)
- 4.2.3 Global Azithromycin Sales Market Share by Type (2021-2032)
- 4.3 Global Azithromycin Revenue by Type
- 4.3.1 Global Azithromycin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Azithromycin Revenue by Type (2021-2032)
- 4.3.3 Global Azithromycin Revenue Market Share by Type (2021-2032)
5 Azithromycin Market by Application
- 5.1 Azithromycin Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Azithromycin Sales by Application
- 5.2.1 Global Azithromycin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Azithromycin Sales by Application (2021-2032)
- 5.2.3 Global Azithromycin Sales Market Share by Application (2021-2032)
- 5.3 Global Azithromycin Revenue by Application
- 5.3.1 Global Azithromycin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Azithromycin Revenue by Application (2021-2032)
- 5.3.3 Global Azithromycin Revenue Market Share by Application (2021-2032)
6 Global Azithromycin Sales by Region
- 6.1 Global Azithromycin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Azithromycin Sales by Region (2021-2032)
- 6.2.1 Global Azithromycin Sales by Region (2021-2026)
- 6.2.2 Global Azithromycin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Azithromycin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Azithromycin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Azithromycin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Azithromycin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Azithromycin Revenue by Region
- 7.1 Global Azithromycin Revenue by Region
- 7.1.1 Global Azithromycin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Azithromycin Revenue by Region (2021-2026)
- 7.1.3 Global Azithromycin Revenue by Region (2027-2032)
- 7.1.4 Global Azithromycin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Azithromycin Revenue (2021-2032)
- 7.2.2 North America Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Azithromycin Revenue (2021-2032)
- 7.3.2 Europe Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Azithromycin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Azithromycin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Azithromycin Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Sandoz
- 8.2.1 Sandoz Company Information
- 8.2.2 Sandoz Business Overview
- 8.2.3 Sandoz Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sandoz Azithromycin Product Portfolio
- 8.2.5 Sandoz Recent Developments
- 8.3 Mylan
- 8.3.1 Mylan Company Information
- 8.3.2 Mylan Business Overview
- 8.3.3 Mylan Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mylan Azithromycin Product Portfolio
- 8.3.5 Mylan Recent Developments
- 8.4 Zydus Pharmaceuticals
- 8.4.1 Zydus Pharmaceuticals Company Information
- 8.4.2 Zydus Pharmaceuticals Business Overview
- 8.4.3 Zydus Pharmaceuticals Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Zydus Pharmaceuticals Azithromycin Product Portfolio
- 8.4.5 Zydus Pharmaceuticals Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Azithromycin Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 Anke Hengyi
- 8.6.1 Anke Hengyi Company Information
- 8.6.2 Anke Hengyi Business Overview
- 8.6.3 Anke Hengyi Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Anke Hengyi Azithromycin Product Portfolio
- 8.6.5 Anke Hengyi Recent Developments
- 8.7 Hainan Poly Pharm
- 8.7.1 Hainan Poly Pharm Company Information
- 8.7.2 Hainan Poly Pharm Business Overview
- 8.7.3 Hainan Poly Pharm Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hainan Poly Pharm Azithromycin Product Portfolio
- 8.7.5 Hainan Poly Pharm Recent Developments
- 8.8 Hainan Hailing Chemipharma Corporation
- 8.8.1 Hainan Hailing Chemipharma Corporation Company Information
- 8.8.2 Hainan Hailing Chemipharma Corporation Business Overview
- 8.8.3 Hainan Hailing Chemipharma Corporation Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Hainan Hailing Chemipharma Corporation Azithromycin Product Portfolio
- 8.8.5 Hainan Hailing Chemipharma Corporation Recent Developments
- 8.9 Wockhardt
- 8.9.1 Wockhardt Company Information
- 8.9.2 Wockhardt Business Overview
- 8.9.3 Wockhardt Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Wockhardt Azithromycin Product Portfolio
- 8.9.5 Wockhardt Recent Developments
- 8.10 Gland Pharma
- 8.10.1 Gland Pharma Company Information
- 8.10.2 Gland Pharma Business Overview
- 8.10.3 Gland Pharma Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Gland Pharma Azithromycin Product Portfolio
- 8.10.5 Gland Pharma Recent Developments
- 8.11 CSPC Ouyi Pharmaceutical
- 8.11.1 CSPC Ouyi Pharmaceutical Company Information
- 8.11.2 CSPC Ouyi Pharmaceutical Business Overview
- 8.11.3 CSPC Ouyi Pharmaceutical Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 CSPC Ouyi Pharmaceutical Azithromycin Product Portfolio
- 8.11.5 CSPC Ouyi Pharmaceutical Recent Developments
- 8.12 Aurobindo Pharma
- 8.12.1 Aurobindo Pharma Company Information
- 8.12.2 Aurobindo Pharma Business Overview
- 8.12.3 Aurobindo Pharma Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Aurobindo Pharma Azithromycin Product Portfolio
- 8.12.5 Aurobindo Pharma Recent Developments
- 8.13 Akorn
- 8.13.1 Akorn Company Information
- 8.13.2 Akorn Business Overview
- 8.13.3 Akorn Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Akorn Azithromycin Product Portfolio
- 8.13.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Azithromycin Value Chain Analysis
- 9.1.1 Azithromycin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Azithromycin Production Mode & Process
- 9.2 Azithromycin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Azithromycin Distributors
- 9.2.3 Azithromycin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst